Search research articles
Contact Us
Filters
Showing results (1-10 of 3) with videos related to
Page
of 1
Sort By:
Leukemia
|
November 23, 2024
miR-196b-Oct1/2 axis regulates DNMT3A-mutant AML pathogenesis
Michael E Lawler, Melanie L Goetz, Jennifer S Romer-Seibert, et al.
Science Advances
|
May 15, 2026
P300/CBP inhibition with inobrodib in combination with gilteritinib and venetoclax targets leukemia stem cells in epigenetic mutant AML
Melanie L Goetz, Jennifer S Romer-Seibert, Amanda M Versace, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 9, 2022
miR-196b-TLR7/8 Signaling Axis Regulates Innate Immune Signaling and Myeloid Maturation in DNMT3A-Mutant AML
Holly A Gamlen, Jennifer S Romer-Seibert, Michael E Lawler, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 3) with videos related to
Sort By:
Page
of 1
Leukemia
|
November 23, 2024
miR-196b-Oct1/2 axis regulates DNMT3A-mutant AML pathogenesis
Michael E Lawler, Melanie L Goetz, Jennifer S Romer-Seibert, et al.
Science Advances
|
May 15, 2026
P300/CBP inhibition with inobrodib in combination with gilteritinib and venetoclax targets leukemia stem cells in epigenetic mutant AML
Melanie L Goetz, Jennifer S Romer-Seibert, Amanda M Versace, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 9, 2022
miR-196b-TLR7/8 Signaling Axis Regulates Innate Immune Signaling and Myeloid Maturation in DNMT3A-Mutant AML
Holly A Gamlen, Jennifer S Romer-Seibert, Michael E Lawler, et al.
Page
of 1